Camp4 Therapeutics (CAMP) Return on Sales (2023 - 2026)

Camp4 Therapeutics' Return on Sales history runs 4 years deep, the most recent figure standing at 0.09% for Q1 2026.

• In Q1 2026, Return on Sales rose 5.0% year-over-year to 0.09%; the TTM figure through Mar 2026 stood at 0.13% (up 22.0% YoY), while the FY2025 annual figure was 0.14%, up 65.0% from the prior year.
• Return on Sales came in at 0.09% for Q1 2026 at Camp4 Therapeutics, up from 0.35% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.08% in Q2 2025 to a low of 1.42% in Q2 2024.
• A 4-year average of 0.35% and a median of 0.19% in 2024 frame the typical range for Return on Sales.
• On a YoY basis, Return on Sales climbed as much as 133 bps in 2025 and fell as far as 14 bps in 2025.
• Camp4 Therapeutics' Return on Sales stood at 0.33% in 2023, then jumped by 39 bps to 0.2% in 2024, then plunged by 70 bps to 0.35% in 2025, then soared by 73 bps to 0.09% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.09%, 0.35%, and 0.17% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison